UC San Francisco |

Early interventions are best for kids with obesity, new guidelines say

The first new clinical guidance in 15 years for treating obesity and overweight in children stresses intensive lifestyle changes while acknowledging barriers.
UCSF Magazine |

Trip therapy

Could psychedelics become mainstream medicines?
UC Davis |

A new downside to coffee? It pollutes

While researchers investigate how caffeine-addicted bacteria may be used as a cleanup crew for caffeine, check out 5 ways to clean up your habit.
UC San Diego |

A new phase for clinical trials

Emerging technologies, social imperatives and the next pandemic are changing how clinical trials look and work.
UC San Diego |

In the wake of a wildfire, changes in cognition and brain function linger

Persons exposed to the deadly Camp Fire in 2018 displayed evidence of what is known as “climate trauma.”
UC Merced |

UC Merced leading effort to boost number of early childhood teachers with $1.8M

The new program will help ensure the youngest California students are ready for the K-12 education system.
UC Riverside |

Gas stoves: Why did they become the pariah du jour?

With the chorus for banning gas stoves growing, a methane expert explains the science behind the rancor.
UC San Francisco |

Ward 86 at 40: Shaping HIV care around the world

The revolutionary Ward 86 turns 40 this year and is still developing new ways to care for people living with HIV.
UC San Diego |

UV-emitting nail polish dryers damage DNA and cause cell mutations

Researchers found devices used to cure gel manicures lead to cell death and cancer-causing mutations in human cells.
UC San Diego |

Cannabis-related emergency department visits among older adults on the rise

Education and discussions with older adults about cannabis use should be included in routine medical care.
UC Davis |

UC Davis researchers study telemedicine for cats

Video veterinary appointments could increase access to medical care.
UC San Francisco |

30 years on, are we winning the fight against Alzheimer’s?

Lecanemab, Donanemab, and other drug-free strategies have emerged as weapons against dementia.